Clinical trial
Safety of Artemether - Lumefantrine, and Other Malaria Drugs and Their Effect on…
NCT00386750 · Novartis Pharmaceuticals, Industry · Terminated
Key facts
| NCT number | NCT00386750 |
|---|---|
| Title | Safety of Artemether - Lumefantrine, and Other Malaria Drugs and Their Effect on the Auditory Function |
| Official title | An Open-label, Single-center Study of the Effects of Co-artemether, Atovaquone-proguanil, and Artesunate-mefloquine on Auditory Function Following the Treatment of Acute Uncomplicated Plasmodium Falciparum Malaria in Patients 12 Years of Age or Older. |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Malaria, Falciparum |
| Intervention type | Drug |
| Interventions | Artemether-lumefantrine |
| Enrollment | 265 |
| Start date | Jun 1, 2005 |
| Primary completion | Nov 1, 2005 |
| Completion | Nov 1, 2005 |
| First posted | Oct 12, 2006 |
| Last update posted | Apr 27, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: